POU transcription factors are involved in transcriptional regulation during early embryonic development and cell differentiation. Oct-4, a member of this family, has been shown to be under strict regulation during murine development. The expression of Oct-4 correlates with the undifferentiated cell phenotype of the mouse preimplantation embryo. In this study, expression of a gene construct consisting of selected parts of the region upstream from the murine Oct-4 gene as promoter/enhancer, enhanced green fluorescent protein (EGFP) as reporter and the five exons of the murine Oct-4 gene (GOF18-⌬PE EGFP) was evaluated in murine, porcine, and bovine preimplantation embryos. For comparison, expression of the endogenous Oct-4 gene was also analyzed in all three species by immunocytochemistry. The transgene construct was microinjected into zygotes cultured in vitro to various developmental stages. The EGFP fluorescence was visualized in developing embryos by excitation with blue light at different days following microinjection and showed similar expression patterns in all three species. Most embryos displayed a mosaic pattern of transgene expression. The EGFP fluorescence was not restricted to the inner cell mass (ICM) but was also seen in trophoblastic cells. An affinity-purified polyclonal antibody specific to Oct-4 was used for immunocytochemical analysis of in vivo-and in vitro-derived bovine and porcine blastocysts and also of in vivo-derived murine blastocysts. In the in vivo-derived murine embryos, Oct-4 protein was detectable in the ICM but not the trophectoderm, whereas in porcine and bovine blastocysts, derived in vivo or in vitro, Oct-4 protein was detected in both the ICM and the trophectoderm. Thus, in the two large animal species, Oct-4 expression from the endogenous gene was clearly not restricted to the pluripotent cells of the early embryo. These results show that Oct-4 regulation differs between these species and that the presence of Oct-4 protein may not be sufficient for selection of undifferentiated cell lines in domestic animals.
INTRODUCTION
The POU domain proteins constitute a family of structurally related transcription factors that have been isolated from a variety of organisms [1, 2] . These proteins are characterized by the presence of a conserved DNA-binding domain, the POU domain, originally identified in the mammalian transcription factors Pit-1, Oct-1, and Oct-2 and in the nematode regulating protein unc-86 [1] . Most POU proteins are expressed during embryogenesis, suggesting that they may play a crucial role in development and cell differentiation [3] [4] [5] . Oct-4 is a member of Class V of the POU transcription factor family (6) (7) (8) . Oct-4 cDNAs have been isolated in several laboratories, and the encoded factor has been termed Oct-4 [6] or Oct-3 [9] . The protein sequence, genomic organization, and chromosomal localization of the POU genes are highly conserved [10, 11] . It has been shown that the murine Oct-4 protein shows extensive sequence similarity with the bovine protein, with an overall identity of 81.7%. The percentages of the amino acid identity for exons 1 through 5 between bovine and murine Oct-4 are 71.0%, 95.1%, 95.4%, 84.9%, and 82.8%, respectively [11] . It has also been shown that the amino acid sequence of the human Oct-4 is 87% identical to that of the mouse, and human Oct-4 expression was found in heart, kidney, liver, placenta, spleen, and pancreatic islets using reverse transcription-polymerase chain reaction (RT-PCR) technology [10] . However, it remains to be shown that Oct-4 protein is present and active in these cell types. The high degree of sequence similarity suggests that Oct-4 plays a similar role in all mammalian species.
Oct-4 is the earliest expressed transcription factor that is known to be crucial in murine preimplantation development [9, [12] [13] [14] , and its effects were recently shown to be dependent on its concentration in the nucleus [15] . Oct-4 mRNA and protein have been found in the unfertilized murine ovum and in the nuclei of subsequent cleavage stages [12, 14, 16, 17] . Oct-4 expression is downregulated during formation of the blastocyst. In the expanded murine blastocyst Oct-4 mRNA and protein are predominantly found in the inner cell mass (ICM) [17, 18] . The ICM differentiates into the epiblast (embryonic ectoderm) and the hypoblast (embryonic endoderm). High levels of Oct-4 protein are found in hypoblast cells as they migrate along the inner surface of the trophectoderm. In the epiblast, Oct-4 expression is high until germ layers start to form. At Day 8.5 of murine gestation Oct-4 becomes restricted to the primordial germ cells [13, 14, 18] .
Oct-4 acts as a transcription factor for many genes specifically expressed in pluripotent cells [19] . This expression pattern suggests that Oct-4 is associated with the status of totipotency, both in the preimplantation embryo and in in vitro culture [7, 9, 12, 20, 21] . The high degree of conservation suggests that these genes might have a similar expression pattern that would make Oct-4 a suitable marker for identification of pluripotent and totipotent cells from domestic species.
In the present study we investigated the potential of individual blastomeres to express from the Oct-4 promoter using the reporter gene construct, GOF18-⌬PE EGFP. This consists of an artificial promoter/enhancer containing elements from the 9-kilobase (kb) region upstream of the murine Oct-4 gene, a reporter gene (enhanced green fluores- cent protein), and the five exons of the murine Oct-4 gene. This construct was microinjected into murine, porcine, and bovine zygotes, and after various periods of in vitro culture, expression was monitored by fluorescence microscopy. In addition, we studied expression of the endogenous Oct-4 gene by whole-mount immunocytochemistry using rigorously purified antibodies specific to Oct-4 in blastocysts of these three species. It has previously been demonstrated that the gene expression profiles of in vitro-produced bovine embryos differ from their in vivo counterparts [22, 23] . Differences have also been reported between in vitroand in vivo-derived porcine embryos [24] [25] [26] . For these reasons, we compared the distribution of Oct-4 protein in in vivo-and in vitro-derived porcine and bovine blastocysts.
MATERIALS AND METHODS

Embryo Collection
Murine embryos. Female CD2F1 mice were superovulated with a 10 IU eCG injection (Sigma, St. Louis, MO) followed by an injection of 10 IU hCG (Sigma) 46 h later and allowed to mate with males of the same strain. The following morning, mating was confirmed by the presence of a vaginal plug. Zygotes were collected 10 h after fertilization by flushing the excised oviducts with PBS supplemented with 1% NBCS (new born calf serum; Boehringer Mannheim, Indianapolis, IN). The cumulus cells were carefully removed from eggs with hyaluronidase (300 g/ml in PBS). Following washing, the zygotes were incubated in PBS supplemented with 10% NBCS until microinjection. Blastocysts from superovulated mice were collected by flushing the uterus with PBS/NBCS (1%) at Day 3.5 postfertilization.
Porcine embryos. Prepuberal gilts were superovulated and used as donors for porcine zygotes and blastocysts [27, 28] . Superovulation was induced by i.m. injections of 1500 IU eCG followed by 500 IU hCG 72 h later. Twenty-five and 34 h later, the gilts were mated or artificially inseminated. Forty-eight hours after the hCG injection they were killed in the Institute's experimental slaughterhouse. The reproductive tract was immediately removed and transported at 37ЊC to the laboratory. Each oviduct was flushed twice with 10 ml PBS containing 1% heat-inactivated NBCS to collect zygotes. After washing they were incubated in PBS with 10% NBCS until microinjection. To produce in vitro-derived porcine blastocysts for immunocytochemistry the in vivo-collected zygotes were cultured in NCSU-23 medium [29] . The culture was maintained in a humidified atmosphere composed of 5% CO 2 in air at 38.5ЊC for up to 7 days until the embryos had reached the blastocyst stage.
In vivo-derived blastocysts were collected by slaughtering donor animals on Days 4 and 5 after mating or artifical insemination and the blastocysts were recovered by flushing each uterine horn with 80 ml PBS/NBCS (1%) [28] .
Bovine embryos. In cattle, zygotes and blastocysts were obtained after in vitro maturation and in vitro fertilization of cumulus-oocyte complexes (COC) [30, 31] . Briefly, the COC from bovine ovaries were isolated via slicing [32] and subsequently matured in vitro in TCM 199 supplemented with 25 mM Hepes (Sigma), 1 g/ml estradiol-17␤ (Serva, Heidelberg, Germany), 0.5 g/ml FSH (Folltropin; Vetrepharm, London, ON, Canada), 0.06 IU/ml hCG (Ekluton; Vemie, Kempen, Germany), and 10% estrus cow serum. In vitro fertilization was performed 22-24 h after initiation of maturation. COC were fertilized in Tyrode medium (FertTalp) supplemented with 0.56 g/ml heparin, 1 M epinephrine, and 10 M hypotaurin. Swimup separated semen was added to the oil-covered fertilization drops each containing 1 ϫ 10 6 spermatozoa/ml [33, 34] . Oocytes and sperm were coincubated for 20 h. Cumulus cells were removed by a 6-min incubation in EDTA (0.2%)/trypsin (0.1%) dissolved in PBS/BSA (1%) followed by repeated pipetting.
Bovine zygotes were cultured in 30-l drops of SOFaaBSA (8 mg/ml fatty acid-free BSA; Sigma), overlaid with silicone oil. Groups of seven to eight embryos were cultured together in a humidified modular incubator chamber at 39ЊC in 5% CO 2 , 7% O 2 , 88% N 2 gas mix for 8 days up to the blastocyst stage.
In vivo-derived blastocysts were recovered nonsurgically from superovulated donor cows on Day 8 after estrus by flushing each uterine horn with 400 ml prewarmed PBS supplemented with 1% NBCS using established procedures.
Oct-4 Reporter Construct
The gene construct (GOF18-⌬PE EGFP) was produced by inserting the EGFP reporter gene between a modified 9-kb promoter fragment of the murine Oct-4 and its structural gene. The modified promoter was produced by removing the proximal enhancer element (PE) from the 18-kb genomic Oct-4 fragment (GOF). The remaining elements of the 9-kb Oct-4 promoter fragment included the GC-box, the hormone response elements (HREs), the binding site for the transcription factor ELP and the distal element (DE) [7] . The EGFP-1 gene (Clontech, Palo Alto, CA) was inserted in frame into an MluI site that had been introduced in front of the initiaton codon ATG of Oct-4 [17] . The construct GOF18-⌬PE EGFP ( Fig. 1) was excised from the plasmid pBluescript II by digestion with NotI, and the resulting 21.2-kb fragment was separated by electrophoresis on a 0.6% agarose gel. The fragment was excised from the gel and purified using the Qiagen gel purification kit. Purified DNA was quantified by optical density and diluted to 7 ng/ l in TE buffer, pH 7.4 (1 mM Tris-Cl, 0.1 mM EDTA). Aliquots of the DNA solution were stored at Ϫ20ЊC prior to microinjection.
Microinjection and Culture of Zygotes
Murine zygotes were placed on a glass microscope slide in a 500-l drop of PBS/NBCS (10%) under the micromanipulator, and the gene construct was injected into pronuclei at 320ϫ magnification. Prior to microinjection, bovine and porcine zygotes were transferred into a microcentrifuge tube and centrifuged for 3 min or 6 min at 15 000 ϫ g, respectively, to displace lipids and visualize the pronuclei.
Swelling of the pronuclei was taken as the criterion indicative of successful microinjection. After injection, intact zygotes were returned to culture. The day of microinjection and the beginning of in vitro culture was defined as Day 1 of embryonic development. Murine embryos were cultured in 100-l drops of M16 medium (Gibco-BRL, Eggenstein, Germany) in a humidified atmosphere of 5% CO 2 and 95% air at 38.5ЊC for 5 days by which time they had developed into blastocysts. Bovine zygotes were cultured for 9 days in SOFaaBSA under incubation conditions described above to produce blastocysts. In vitro development of porcine embryos was observed in four-well tissue culture plates (Nunc, Roskilde, Denmark) filled with 500 l of culture medium NCSU-23 for 8 days under the same conditions described for mice. Control embryos without any manipulation were placed directly into culture media after flushing or fertilization.
Determination of EGFP Fluorescence in the Embryos
The EGFP fluorescence was evaluated on Days 3 and 5, respectively, after fertilization for mice, and on Days 5 and 8, respectively, after fertilization for cow and pig embryos using a fluorescent microscope with an excitation-filter at 488 nm and a bandpass (500 to 530 nm) emission-filter. At the same time, the cleavage rate (more than two blastomeres) and percentage of embryos that developed to morulae and blastocysts were recorded. The proportion of positive embryos (i.e., those with at least one fluorescing blastomere) and the distribution of fluorescing blastomeres within each embryo was assessed. In addition, the proportion of EGFP-positive blastomeres was determined in relation to all blastomeres within the embryo.
Polyclonal Oct-4 Antiserum
The antiserum used was a polyclonal antibody raised in rabbits against Oct-4. Antibodies were enriched from the serum by a Prot A Sepharose column. A rigorous purification procedure using a double affinity column was necessary to remove cross-reactivity with other POU proteins [14] . The specificity of the Oct-4 antibody was confirmed immunohistochemically on Western blots that included Oct-4 protein, the POU region of Oct-1, and the Oct-6 protein.
Immunocytochemistry
Whole-mount immunocytochemistry was performed on blastocysts from mouse, cow, and pig. Following double washing in PBS supplemented with BSA (4 mg/ml), the embryos were fixed for 30 min in freshly prepared 3% paraformaldehyde in PBS and permeabilized by incubation in PBS containing 0.2% Triton X-100 (Koch-Light Laboratories Ltd., Haverhill, Suffolk, UK). Nonspecific immunoreactions were blocked with 3% FCS (fetal calf serum) and 0.1% Tween-20 (Sigma) in PBS. Quenching of nonspecific binding on free aldehyde groups was accomplished with 50 mM glycine (Sigma) in Tween/FCS blocking buffer for 15 min. Following this pretreatment, the affinity-purified primary polyclonal antibody raised against Oct-4 and diluted 1:400 in PBS was applied for 30 min at room temperature. To remove all free Oct-4 antibodies, the embryos were washed extensively for 5 to 10 min in blocking buffer. After washing, the samples were incubated with secondary Alexa 488-conjugated goat antirabbit IgG (Molecular Probes, Eugene, OR) diluted to 1:2000 for 20 min at room temperature. After additional washing the embryos were incubated in PBS containing propidium iodide (30 g/10 ml PBS) for 2 h in the dark. They were then mounted on slides in 10% DABCO solution in glycerol (1,4-diazabicyclo [2,2,2]-octane; Sigma) after going through an increasing glycerol series (5%, 10%, 20%, 30%, 40%, 50%, 60%, 80%, 90%). Controls were produced using only the secondary antibody or by omission of both antibodies.
Confocal Laser Scanning Microscopy
The embryos were analyzed on the EMBL confocal scanning laser microscope. An excitation wavelength of 488 nm was selected from an argon-ion laser to excite the Alexa-conjugated secondary antibody and 529 nm wavelength to excite propidium iodide. Images of serial optical sections were recorded every 1.5-to 2-m vertical step along the Z-axis of each embryo. Three-dimensional images were constructed using appropriate software written for the EMBL confocal microscope.
Statistical Analysis
Percentages of zygotes that had cleaved and formed blastocysts and showed EGFP expression were calculated as a proportion of total injected or noninjected zygotes that continued to develop. To determine differences in cleavage rate and blastocyst formation, the chi-square test was performed using 2 by 2 contingency table classifications. Immunocytochemical results were confirmed in at least two replicate experiments.
RESULTS
Expression of GOF18-⌬PE EGFP During Early Development
A total of 241, 161, and 208 zygotes from mouse, pig, and cow, respectively, were injected with the experimental gene construct GOF18-⌬PE EGFP. Cleavage rates and the proportion of cleaved embryos that developed further to the blastocyst stage are shown in Table 1 .
Examination at Day 3 (mice) and Day 5 (pigs and cattle) revealed two-and four-cell embryos but also zygotes that had failed to divide. The numbers of embryos showing fluorescence both before and after major activation of the embryonic genome (MET) are shown in Table 2 . Murine MET occurs at the 2-cell stage, porcine MET takes place at the 4-cell stage, and bovine MET occurs at the 8-to 16-cell stage [35] . The overall cleavage rate of murine and bovine embryos was significantly higher in the noninjected controls than in the injected groups, but no significant differences were observed between the cleavage rate of the noninjected and injected groups of porcine embryos. The proportion of cleaved porcine and bovine embryos that developed to blastocysts was not affected by injection. However, the development of murine blastocysts was higher in noninjected than in microinjected zygotes. The ability to express the experimental gene construct (GOF18-⌬PE EGFP), as indicated by the presence of green fluorescence, was observed in all developmental stages from the zygote up to the blastocyst stage and in all cell types in all three species. Varying degrees of green fluorescence intensity were observed in 16.2%, 34.2%, and 9.6% of murine, porcine, and bovine microinjected embryos, respectively ( Table 3 ). As shown in Table 2 , most of the fluorescing embryos displayed a mosaic pattern of expression (Fig. 2) . While the proportion of positive cells varied considerably, most embryos showed fluorescence in less than half of their blastomeres. Only a few two-cell stages and a single murine blastocyst exhibited fluorescence in all blastomeres. In blastocysts, fluorescence was frequently restricted to a few or even single blastomeres. The intensity of fluorescence also varied considerably and embryos typically contained a range of strongly fluorescing, weakly fluorescing, and nonfluorescing blastomeres. The distribution of positive blastomeres was random. There was no relationship between EGFP/Oct-4 expression and developmental stage. Contrary to expectations, fluorescence was not restricted to the cells of the ICM but was also seen in trophectodermal cells (Fig. 3) .
Oct-4 Protein Distribution in Blastocysts
A total of 42 in vivo-derived murine blastocysts were assessed by immunocytochemistry. Among these, the pattern of Oct-4 immunostaining depended on the developmental stage of the embryo. In early blastocysts, Oct-4 protein was detected in the ICM as well as in trophectoderm. The Oct-4 protein was in all cases localized to the nucleus. During formation and maturation of ICM and trophectoderm, the Oct-4 signal disappeared from the trophectoderm, and in expanded blastocysts the Oct-4 signal was restricted to the ICM (Fig. 4) .
Examination of bovine blastocysts showed no such relationship. In contrast to murine blastocysts, immunostaining of Oct-4 in 108 fully expanded, in vitro-derived bovine blastocysts revealed Oct-4 in the ICM as well as in trophectodermal cells (Fig. 5) . The Oct-4 signal was observed in the cytoplasm as well as in nuclei of these cells. A similar picture was seen for 43 in vivo-derived bovine blastocysts.
The distribution pattern of Oct-4 protein in 23 porcine in vitro-derived embryos and in 86 in vivo-derived embryos was similar to that observed in bovine blastocysts in that Oct-4 protein was present both in the ICM and in the trophectoderm (Fig. 6) . A diffuse distribution of the Oct-4 signal was present in both cytoplasm and nuclei. No staining was observed in control embryos in which the primary antibody had been omitted (data not shown).
DISCUSSION
This is the first study in which it was shown that an artificial promoter sequence based on modification to the 9-kb region upstream of the murine Oct-4 gene functions in three different mammalian species: mice, cattle, and pigs. This indicates that these species have similar control mechanisms for this promoter sequence and importantly opens the possibility of using a cell sorter to selecting cells that are expressing Oct-4 at a specific level. The results also demonstrated that this promoter was active in all cell types of all preimplantation stages in all three species, although the proportion of EGFP-positive embryos differed somewhat between the three species. This is consistent with previous observations [36, 37] that indicate that the expression of an injected transgene is not noticeably affected by factors controlling major activation of embryonic genome (MET).
A direct comparison of microinjection with in vitro-and in vivo-derived porcine zygotes showed that in vivo embryos had a higher cleavage rate [38] . The present study supports this generalization to the extent that the cleavage rate following microinjection of the in vitro-produced bovine zygotes was lower than that of the in vivo-derived murine and porcine zygotes. The fact that there was also a lower yield of fluorescing embryos from the microinjection of bovine zygotes supports the hypothesis that there are other factors unique to bovine embryos that make them more resistant to this stress than other species [39] [40] [41] .
Mosaicism in the expression patterns and in the expression intensity of injected transgenes has been observed in several laboratories [36, 37, [42] [43] [44] [45] [46] , and while some laboratories have reported a lower proportion of mosaicism under similar conditions [37, 46] , it would appear that mosaicism is a characteristic of the injection procedure itself and not of a particular gene construct [42] [43] [44] [45] . The occurrence of mosaics can be explained by the timing of integration, unequal distribution of the nonintegrated DNA during cell division, extrachromosomal replication of the injected DNA [36, 46] , or loss of an integrated transgene during early development [47] . Our findings are consistent with a recent report showing that embryos expressing a microinjected gene uniformly were transgenic, while embryos with mosaic expression were nontransgenic [48] .
To gain insight into the expression pattern of the endogenous Oct-4 gene, the spatial localization of Oct-4 protein was determined by immunocytochemistry using a wellcharacterized polyclonal antibody with no cross-reactivity to other POU domain proteins as determined by Western blot analysis. We focused on the blastocyst stage when the first differentiated tissue of the preimplantation embryo appears. In murine blastocysts, Oct-4 protein was not detectable in cells of the trophectoderm as reported in earlier studies [13, 14, 17] ; however, even in fully expanded bovine and porcine blastocysts, both cell types were positive.
Previously, Oct-4 mRNA and protein were observed in in vitro-produced preattachment stage bovine embryos using antibodies whose specificity was determined empirically by testing on differentiated and undifferentiated P19 cells [11] . Furthermore Oct-4 mRNA was detected by reverse transcription-T7 RNA-dependent amplification in both the trophectoderm and the primitive ectoderm at Days 10 and 11 of porcine pregnancy [49] . The single major difference between murine, porcine, and bovine blastocysts was that Oct-4 protein was not detected in the murine trophectoderm.
The early preimplantation development of mouse, pig, and cow is similar in that the embryos of these mammalian species all progress through three major morphogenetic transitions, compaction, cavitation, and expansion, finally leading to hatching and implantation. However, some differences are evident. One difference between murine embryos and those of larger mammals is in the timing of genetic and morphological transitions [35, 50] . Another difference is that cell fates in murine preimplantation development are more stringently regulated. For example, according to the inside/outside hypothesis, the two cell populations producing ICM and trophectoderm in the mouse are derived from the inner and outer cell layers of the morula [51] . In porcine and bovine embryos, compaction and ICM allocation seem to be independent processes and allocation may even be random [52] . The delayed downregulation of Oct-4 in large mammals may be the consequence of the lengthened period of preimplantation development. It may be necessary to study Oct-4 expression in porcine and bovine blastocysts between Days 8-15 and 8-23, respectively, to observe downregulation of Oct-4 expression in the trophectoderm in these species.
Following blastulation, greater differences in development are observed between the three species examined in this study. Murine embryos form an egg cylinder stage, whereas in livestock germinal disc-stage embryos are observed [53] . In the mouse, hatching and implantation occur more or less simultaneously, whereas in domestic species development is characterized by delayed implantation [50, 54] . In particular, the trophectoderm has characteristic differences among these three species. In mice, expansion of the blastocyst is relatively modest and the growth of the trophoblast is accomplished by mitosis only among the trophectoderm cells overlying the ICM [55] . Murine trophectoderm cells are end cells and are dependent upon contact with the ICM to retain their ability to proliferate. In fact, it has been proposed that murine ICM cells may become externalized and as such contribute to the trophectoderm lineage [56] . In contrast, the porcine trophoblast continues dividing and expands several orders of magnitude prior to implantation [57] . The bovine trophoblast also expands more than the murine trophoblast but not quite so extensively as the porcine trophoblast [50] . In mice, the decrease of Oct-4 levels in the trophoblast and the increase of Oct-4 protein in the primitive endoderm (hypoblast) suggest that as a transcription factor Oct-4 regulates both genes involved in determining cell commitment and genes involved in the regulation of proliferation in specific cell lineages [17] . Our findings support this hypothesis in that Oct-4 levels decreased in the trophectoderm of murine blastocysts at the time when proliferation is terminated but remained higher in the trophectoderm of the two domestic animal species that show high proliferative activity at this stage of development.
In addition to the comparison of endogenous Oct-4 protein distribution between murine, porcine, and bovine blastocysts, the distribution within in vitro-produced bovine and porcine blastocysts was compared to that of their in vivo counterparts. Several studies have demonstrated that in vitro-produced bovine and porcine embryos display a number of marked differences compared with their in vivo-derived counterparts, including morphology, color, cell number and cell size, timing of development [24, 25, 58] , cellular damage (broken DNA) [26] , and resistance to freezing [59, 60] . In bovine and murine embryos it has been demonstrated, that a variety of genes are differently expressed in in vivoderived embryos compared with embryos produced in vitro [23] . In contrast, no differences were detected between in vivo-and in vitro-produced bovine or porcine blastocysts with regard to the Oct-4 protein distribution in the present study. It remains to be determined whether differences exist in the endogenous Oct-4 mRNA levels. Although there were no differences in the Oct-4 protein distribution between in vivo-and in vitro-produced embryos, the analysis of other such markers of embryo development could be useful for the evaluation of in vitro-produced embryos.
Oct-4 is presumed to be a critical factor controlling murine, bovine, and porcine preimplantation embryonic development. The striking finding in the present study is that Oct-4 protein in pig and cow was detected in the ICM and in the trophectoderm. In the mouse, Oct-4 expression correlates with the undifferentiated cell type, suggesting that Oct-4 is a marker for pluripotency. Its expression is crucial for maintenance of the pluripotent phenotype in nascent murine ICM cells [61] , although residual Oct-4 protein is occasionally detected in cells of the murine trophectoderm in early blastocysts [17] . The detection of Oct-4 protein in the trophectoderm of porcine and bovine expanded blastocysts indicates that it may be the biological activity of Oct-4, and not simply its presence, that correlates with the embryonal stem cell type. Cytokines, such as leukemia inhibitory factor, are similarly important for maintenance of the undifferentiated/pluripotent state in embryonic stem cell cultures [62] . Recently, it was demonstrated that the level of Oct-4 expression is responsible for the maintenance or loss of pluripotency in preimplantation embryos [15] .
In conclusion, data from our experiments reveal that there are marked differences in Oct-4 regulation between mice and larger mammals-especially the pig, which had not been previously studied. This study has established that a single construct, based on the 9-kb promoter sequence of the murine Oct-4 gene (GOF18-⌬PE EGFP) and green fluorescent protein, is expressed in three different mammalian species: mice, cattle, and pigs. It is now recognized that the mere presence of Oct-4 protein or Oct-4 transcription do not define pluripotency because it is the level of expression that is the key to regulation [15] , and it is necessary to measure Oct-4 activity quantitatively. Further experiments are needed to confirm that the level of bovine and porcine Oct-4 expression, as indicated by GOF18-⌬PE EGFP, regulates pluripotency in the same manner as in the murine system. If this is the case, this construct will serve as a tool for selection of pluripotent cells.
